Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMIG4.L Regulatory News (MIG4)

  • There is currently no data for MIG4

Interim Management Statement

8 May 2017 15:02

RNS Number : 5001E
Mobeus Income & Growth 4 VCT PLC
08 May 2017
 

 

Mobeus Income & Growth 4 VCT plc ("the Company")

Legal Entity Identifier (LEI): 213800IFNJ65R8AQW943

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 31 March 2017

 

Mobeus Income & Growth 4 VCT plc reports an Interim Management Statement for the quarter ended 31 March 2017. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

At 31 March 2017

At 31 December 2016

Net assets attributable to shareholders

£50,867,779

£52,755,156

Shares in issue

49,749,171

49,043,033

Net asset value (NAV) per share

102.25p

107.57p

Cumulative dividends paid

80.20p

73.20p

Cumulative Total return (net asset value basis) per share since inception

182.45p

180.77p

The NAV per share fell by 5.32 pence over the quarter, principally due to the payment of 7.00 pence per share in dividends in the quarter, referred to below. The underlying increase in NAV per share was due to an increase in the value of the portfolio and income returns.

 

DIVIDENDS

A second interim dividend of 7.00 pence per share for the year ended 31 December 2016 was paid on 17 March 2017. This brought the dividends paid in respect of the year ended 31 December 2016 to 9.00 pence per share and cumulative dividends paid since inception to 80.20 pence per share.

 

DIVIDEND INVESTMENT SCHEME

Under the Dividend Investment Scheme a total of 706,138 ordinary shares were issued to shareholders wishing to reinvest their dividends on 17 March 2017. Following the share issue there were 49,749,171 ordinary shares in issue.

 

NEW INVESTMENT

The Company made two new investments in the quarter. The first of these was a £0.58 million investment in January 2017 into Ibericos Etc (trading as Tapas Revolution), a leading Spanish restaurant chain in the casual dining sector. The second was a £0.53 million investment in March 2017 into Buster & Punch, a premium brand business which designs a range of high quality lighting and electrical fittings for the home.

Finally, a loan envisaged when the initial investment in BookingTek Limited was made in October 2016, was advanced for £0.07 million.

 

DIVESTMENTS

No divestments occurred during the quarter to 31 March 2017, although sundry receipts of £0.17 million were received, of which £0.08 million was further deferred consideration in respect of earlier disposals of two investments realised in a prior period, being Focus Pharma and MachineWorks.

 

LOAN STOCK REPAYMENTS

The VCT received £4.36 million of loan repayments in the quarter.

 

SHARE BUYBACKS

The Company did not conduct any share buybacks during the period.

 

ANNUAL GENERAL MEETING

The Company is pleased to announce that all the resolutions proposed at the Annual General Meeting of the Company held today, 8 May 2017, were approved by shareholders.

 

 

For further information, please contact:

Jonathan McGuire, for Mobeus Equity Partners LLP, Company Secretary: 020 7024 7615.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZVLFBDEFBBBF
Date   Source Headline
16th Apr 20205:45 pmRNSAnnual Financial Report
16th Apr 20205:45 pmRNSDividend Investment Scheme - Recommencement
2nd Apr 20205:10 pmRNSIssue of Equity
2nd Apr 202010:00 amRNSDividend Declaration
30th Mar 202012:51 pmRNSPublication of Suppl.Prospcts
27th Mar 20207:00 amRNSNet Asset Value(s)
25th Feb 20203:15 pmRNSPublication of Suppl.Prospcts
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
7th Feb 20206:40 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:37 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:36 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:34 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:30 pmRNSPublication of Suppl.Prospcts
3rd Feb 202011:30 amRNSTotal Voting Rights
8th Jan 20204:31 pmRNSFundraising Update
8th Jan 20204:20 pmRNSIssue of Equity & Total Voting Rights
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
13th Dec 20195:50 pmRNSDividend Declaration
13th Dec 20199:15 amRNSTransaction in Own Shares
27th Nov 20194:15 pmRNSInterim Management Statement - 3rd Quarter Results
27th Nov 20191:52 pmRNSDividend Declaration
26th Nov 20195:00 pmRNSDirectorate Change
19th Nov 201912:00 pmRNSFundraising Update
25th Oct 20194:00 pmRNSPublication of a Prospectus
21st Oct 201912:57 pmRNSDirector Declaration
11th Oct 20193:00 pmRNSResult of Meeting
1st Oct 201910:00 amRNSTotal Voting Rights
27th Sep 201912:00 pmRNSTransaction in Own Shares
10th Sep 20195:00 pmRNSNotice of GM
10th Sep 20195:00 pmRNSNotice of GM
10th Sep 20195:00 pmRNSNotice of GM
10th Sep 20195:00 pmRNSFundraising Update, Circular and General Meetings
14th Aug 201911:05 amRNSNational Storage Mechanism
8th Aug 201910:54 amRNSHalf-year Report
31st Jul 20197:00 amRNSReduction of Capital
29th Jul 201911:00 amRNSShare buyback policy objective
29th Jul 20197:00 amRNSIntention to launch offers for subscription
3rd Jul 201911:33 amRNSRealisation of investment
20th May 20199:28 amRNSTransaction in Own Shares
15th May 201910:16 amRNSTransaction in Own Shares
13th May 201910:10 amRNS1st Quarter Results - Interim Management Statement
10th May 20192:08 pmRNSDirectorate Change
10th May 20192:05 pmRNSResult of AGM
27th Mar 201910:48 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.